[Elsevier/Sciencedirect] Real-world impact of first-line nivolumab plus chemotherapy on conversion surgery and survival outcomes in advanced gastric and esophagogastric junction cancer: a propensity score-matched analysis

E.Jiang 发表于 1 小时前 | 显示全部楼层 |阅读模式
此帖将于 2026-10-13 15:02 自动关闭
悬赏30积分


DOI号:10.1016/j.gassur.2026.102532

文献链接:https://www.sciencedirect.com/sc ... i/S1091255X26002131

文献作者:

备注信息:

[size=1em]Volume 30, Issue 10, October 2026, 102532


Real-world impact of first-line nivolumab plus chemotherapy on conversion surgery and survival outcomes in advanced gastric and esophagogastric junction cancer: a propensity score-matched analysis
Author links open overlay panelAkihiko Sano, Nobuhiro Nakazawa, Kengo Kuriyama, Takuhisa Okada, Takuya Shiraishi, Yuji Kumakura, Akiharu Kimura

全部回复0 显示全部楼层

发表回复

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

VIP会员
  • 发布

  • 回复

  • 积分

    1885

返回列表